ArticleCureus2025
Tuberculosis Coinciding With Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma: A Diagnostic Conundrum.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) and lung carcinoma can coexist, creating diagnostic and therapeutic difficulties leading to poor patient outcomes, especially in a TB-endemic country like India. Here, we report an interesting case of a female patient in her 40s who presented with shortness of breath and a weight loss of 15 kg over 10 months. Her imaging findings include a right-sided pleural effusion, right parahilar lesion, and mediastinal lymphadenopathy. Medical thoracoscopy was done, and the pleural biopsy was positive for GeneXpert MTB. She responded initially to anti-TB therapy. However, she developed a new lytic lesion over the right proximal shoulder and a progression of her initial radiological findings. She was evaluated further, which revealed EGFR (epidermal growth factor receptor)-mutated lung adenocarcinoma. Hence, a diagnosis of coexistent TB and lung adenocarcinoma was made. She was lost to follow-up, and a telephonic call revealed she had died two years later.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.